絞り込み

16514

広告

「rivaroxaban」の検索結果

4044件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Rebleeding vs Thromboembolism After Hospitalization for Gastrointestinal Bleeding in Patients on Direct Oral Anticoagulants.

An analysis on distribution and inter-relationships of biomarkers under rivaroxaban in Japanese patients with non-valvular atrial fibrillation (CVI ARO 1).

Reduced dose direct oral anticoagulants in the extended treatment of venous thromboembolism: a systematic review and meta-analysis.

Pathological Findings of Rivaroxaban-Associated Hemorrhagic Pericarditis.

In vitro efficacy of pro- and anticoagulant strategies in compensated and acutely ill patients with cirrhosis.

Catheter ablation for atrial fibrillation on uninterrupted direct oral anticoagulants: A safe approach.

[Issues of antithrombotic therapy in ACS patients with atrial fibrillation].

Pharmacogenetics of novel oral anticoagulants: a review of identified gene variants & future perspectives.

Prevalence of Left Atrial Thrombus Detection by Transesophageal Echocardiography: A Comparison of Continuous Non-Vitamin K Antagonist Oral Anticoagulant Versus Warfarin Therapy in Patients Undergoing Catheter Ablation for Atrial Fibrillation.

Safety of Catheter Ablation for Atrial Fibrillation in Patients With Prior Cerebrovascular Events.

Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source.

Atrial fibrillation and ischemic events with rivaroxaban in patients with stable coronary artery disease (AFIRE): Protocol for a multicenter, prospective, randomized, open-label, parallel group study.

Oral anticoagulation and left atrial thrombi resolution in non-rheumatic atrial fibrillation or flutter: A systematic review and meta-analysis.

Predictors of self-reported adherence to direct oral anticoagulation in a population of elderly men and women with non-valvular atrial fibrillation.

Model-based meta-analysis to evaluate optimal doses of direct oral factor Xa inhibitors in atrial fibrillation patients.

Gender-based differences in hemostatic responses.

The Effects of Dabigatran and Rivaroxaban on Markers of Polymorphonuclear Leukocyte Activation.

Management of venous thromboembolism with non-vitamin K oral anticoagulants: A review for nurse practitioners and pharmacists.

Emergency Department Discharge of Pulmonary Embolus Patients.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります